GSK
GSK plc
NYSE · Healthcare · Drug Manufacturers - General · GB
$49.89
−1.93%Forward multiples
Based on analyst estimates
- P/E forward
- 9.84x
- P/E 2026E
- 10.30x
- P/E 2027E
- 9.63x
- P/E 2028E
- 9.15x
- P/S forward
- 2.12x
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.37x
- PEG TTM
- 0.27x
- Price / book
- 4.21x
- Price / sales
- 2.23x
- Price / cash flow
- 8.46x
Enterprise value
- Enterprise value
- $119.7B
- EV / sales
- 2.66x
- EV / EBITDA
- 8.14x
- EV / EBIT
- 12.87x
- Market cap
- $100.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026